Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06364449
Status:
RECRUITING
Last Update Posted:
2024-04-15
First Post:
2024-04-09
Brief Title:
Clinical Decision Tree Analysis of Hemodialysis Arteriovenous Access Choices and Creations - a Multiple-center Retrospective Cohort Study
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
Clinical Decision Tree Analysis of Hemodialysis Arteriovenous Access Choices and Creations - a Multiple-center Retrospective Cohort Study
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Our study aim was to utilize a decision tree analysis DTA model to gain insight into the decision-making process within a multiple-center cohort
Detailed Description:
Scientific research focuses on limited parameters aims to confirm hypotheses and has minor uncertainties In contrast medical decisions involve many unknowns Physicians must use all available knowledge to make the best decisions However decision-making can become unpredictable when limited evidence exists leading to non-reproducible outcomes
According to clinical guidelines patients who need pre-kidney replacement therapy pre-KRT and opt for hemodialysis HD with a reasonable life expectancy should have arteriovenous AV access created Nevertheless constructing an AVF has limitations Additionally the maturation rate of AVF is suboptimal Therefore after careful consideration of the patients end-stage kidney disease ESKD life plan the suggested order of AV access types and locations starts a native distal forearm radiocephalic AVF followed by a native proximal forearm AVF a forearm arteriovenous graft AVG then an upper arm AVG creationLok et al 2020 However the decision-making process for selecting hemodialysis access is shared between patients physicians and the surgeons discretion
Therefore clinical kidney practice requires effective decision-making to address ESKD life plan and AV access concerns while minimizing harm Decision analysis models can bridge the gap between research and decision-making Our study aim was to utilize a decision tree analysis DTA model to gain insight into the decision-making process within a multiple-center cohort
According to clinical guidelines patients who need pre-kidney replacement therapy pre-KRT and opt for hemodialysis HD with a reasonable life expectancy should have arteriovenous AV access created Nevertheless constructing an AVF has limitations Additionally the maturation rate of AVF is suboptimal Therefore after careful consideration of the patients end-stage kidney disease ESKD life plan the suggested order of AV access types and locations starts a native distal forearm radiocephalic AVF followed by a native proximal forearm AVF a forearm arteriovenous graft AVG then an upper arm AVG creationLok et al 2020 However the decision-making process for selecting hemodialysis access is shared between patients physicians and the surgeons discretion
Therefore clinical kidney practice requires effective decision-making to address ESKD life plan and AV access concerns while minimizing harm Decision analysis models can bridge the gap between research and decision-making Our study aim was to utilize a decision tree analysis DTA model to gain insight into the decision-making process within a multiple-center cohort
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None